A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
Condition: Hemophilia A Intervention: Drug: Efanesoctocog Alfa BIVV001 Sponsor: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT ®
Condition: Hemophilia Intervention: Drug: SEVENFACT® Sponsor: Laboratoire français de Fractionnement et de Biotechnologies Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials